Concepedia

Melvin Spigelman

MS

28

Publications

3.8K

Citations

24

H-Index

1983

Active since

Affiliations

TB Alliance(Current)

Task Applied Science

University College London

University of Cape Town

Stellenbosch University

Melvin Spigelman is an author at TB Alliance specializing in medicine, pharmacology, and drug resistance.

Top concepts

Publications per year

1983–2024

28

Publications

28

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane et al. · New England Journal of Medicine · 2020 · 962 citations · Full text

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

Francesca Conradie, Tatevik R. Bagdasaryan, Pauline Howell et al. · New England Journal of Medicine · 2022 · 507 citations · Full text

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

Andreas H. Diacon, Rodney Dawson, Florian von Groote-Bidlingmaier et al. · The Lancet · 2012 · 428 citations

, , +12

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · New England Journal of Medicine · 2022 · 318 citations · Full text

Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

Rodney Dawson, Andreas H. Diacon, Daniel E. Everitt et al. · The Lancet · 2015 · 248 citations

, , +9

Rows per page

1–5 of 28